← Open Payments lookup

KATELYN KLEMAIER: Open Payments

NPI 1588405625 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$970 in 39 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $970

Food & beverage: $970
CompanyPaymentsAmount
UCB, Inc.5$124
CATALYST PHARMACEUTICALS, INC.3$96
JAZZ PHARMACEUTICALS INC.3$88
SK Life Science, Inc.3$84
HARMONY BIOSCIENCES LLC2$65
ABBVIE INC.3$64
Lundbeck LLC2$58
GENZYME CORPORATION2$54
Celgene Corporation2$48
Genentech USA, Inc.2$47

Products named: Nayzilam, FYCOMPA, WAKIX, EPIDIOLEX, VYEPTI, QULIPTA, ZEPOSIA, Ocrevus.

Industry payments across IN — which companies pay providers there.